First US FDA Indication-Specific Draft Guidance Of Trump/Makary Era Signals More Normalcy

 
• By Michael McCaughan
  
Guidance releases have increased in recent months after being paused at the start of the Trump Administration. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from United States